| No complications | VAP | Atelectasis | p‐value# |
Total cell count ×103 | 184±38 | 178±42 | 186±35 | 0.14 |
Alveolar macrophage % | 83±9 | 83±7 | 85±6 | 0.53 |
Neutrophils % | 11±5 | 14±5 | 12±4 | 0.055 |
Total protein µg·mL−1 | 148±62 | 177±58 | 166±53 | 0.12 |
Albumin µg·mL−1 | 40±19 | 55±17 | 56±18 | 0.28 |
PAF pg·mL−1 BAL | 1±3 | 0 | 0 | 0.51 |
PAF-AcH nmol PAF·mL−1 BAL·min−1 | 0.05±0.02 | 0.06±0.03 | 0.06±0.03 | 0.52 |
Total PL µg·mL−1 BAL | 2.7±1.1 | 2.6±0.8 | 2.8±0.9 | 0.87 |
PC % of total PL | 71±5 | 70±12 | 68±12 | 0.76 |
PG % of total PL | 10±3 | 9±2 | 8±2 | 0.74 |
SM % of total PL | 6±1 | 5±1 | 6±2 | 0.84 |
PE % of total PL | 4±1 | 4±1 | 4±1 | 0.48 |
PS % of total PL | 4±2 | 5±1 | 5±2 | 0.75 |
PI % of total PL | 5±2 | 5±1 | 5±1 | 0.62 |
Lyso-phosphatidylcholine % of total PL | 0 | 0 | 0 | 0.8 |
Died n (%) | 6 (27%) | 5 (41%) | 3 (37%) | 0.08 |
MV days | 19±5 | 27±8* | 17±5 | 0.042 |
MODS n (%) | 4 (18%) | 4 (33%) | 2 (25%) | 0.09 |